156 related articles for article (PubMed ID: 20567673)
1. Experimental models of composite tissue allograft transplants.
Siemionow M; Kulahci Y
Semin Plast Surg; 2007 Nov; 21(4):205-12. PubMed ID: 20567673
[TBL] [Abstract][Full Text] [Related]
2. Composite tissue allotransplantation.
Siemionow MZ; Kulahci Y; Bozkurt M
Plast Reconstr Surg; 2009 Dec; 124(6 Suppl):e327-e339. PubMed ID: 19952701
[TBL] [Abstract][Full Text] [Related]
3. Immune responses in transplantation: application to composite tissue allograft.
Klimczak A; Siemionow M
Semin Plast Surg; 2007 Nov; 21(4):226-33. PubMed ID: 20567675
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the rat hind limb transplant as an experimental model of vascularized composite allotransplantation: Approaches and advantages.
Fleissig YY; Beare JE; LeBlanc AJ; Kaufman CL
SAGE Open Med; 2020; 8():2050312120968721. PubMed ID: 33194200
[TBL] [Abstract][Full Text] [Related]
5. Characterization, prophylaxis, and treatment of infectious complications in craniomaxillofacial and upper extremity allotransplantation: a multicenter perspective.
Broyles JM; Alrakan M; Ensor CR; Khalifian S; Kotton CN; Avery RK; Brandacher G; Lee WPA; Gordon CR
Plast Reconstr Surg; 2014 Apr; 133(4):543e-551e. PubMed ID: 24675206
[TBL] [Abstract][Full Text] [Related]
6. Impact of donor bone marrow on survival of composite tissue allografts.
Siemionow M; Nasir S
Ann Plast Surg; 2008 Apr; 60(4):455-62. PubMed ID: 18362579
[TBL] [Abstract][Full Text] [Related]
7. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
[TBL] [Abstract][Full Text] [Related]
8. Basics of immune responses in transplantation in preparation for application of composite tissue allografts in plastic and reconstructive surgery: part I.
Siemionow M; Klimczak A
Plast Reconstr Surg; 2008 Jan; 121(1):4e-12e. PubMed ID: 18176199
[TBL] [Abstract][Full Text] [Related]
9. Allograft mass as a possible contributing factor to the skin transplant outcome.
Ulusal BG; Ulusal AE; Wei FC; Lin CY
J Surg Res; 2010 Jun; 161(2):321-7. PubMed ID: 20478759
[TBL] [Abstract][Full Text] [Related]
10. Is Skin the Most Allogenic Tissue in Vascularized Composite Allotransplantation and a Valid Monitor of the Deeper Tissues?
Robbins NL; Wordsworth MJ; Parida BK; Kaplan B; Gorantla VS; Weitzel EK; Breidenbach WC
Plast Reconstr Surg; 2019 Apr; 143(4):880e-886e. PubMed ID: 30921156
[TBL] [Abstract][Full Text] [Related]
11. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
[TBL] [Abstract][Full Text] [Related]
12. Current status of vascularized composite tissue allotransplantation.
Edtinger K; Yang X; Uehara H; Tullius SG
Burns Trauma; 2014; 2(2):53-60. PubMed ID: 27602363
[TBL] [Abstract][Full Text] [Related]
13. Tolerance and future directions for composite tissue allograft transplants: part II.
Siemionow M; Klimczak A
Plast Reconstr Surg; 2009 Jan; 123(1):7e-17e. PubMed ID: 19116508
[TBL] [Abstract][Full Text] [Related]
14. Cryopreservation and Transplantation of Vascularized Composite Transplants: Unique Challenges and Opportunities.
Shani N; Friedman O; Arav A; Natan Y; Gur E
Plast Reconstr Surg; 2019 May; 143(5):1074e-1080e. PubMed ID: 31033834
[TBL] [Abstract][Full Text] [Related]
15. Vascularized bone marrow allotransplantation and low-dose cyclosporine prolong the survival of adipose tissue allografts.
Hsieh YH; Chen WF; Huang JJ; Wu CW; Engel H; Cheng MH
Plast Reconstr Surg; 2012 Jul; 130(1):64-72. PubMed ID: 22743874
[TBL] [Abstract][Full Text] [Related]
16. Vascularized composite allograft-specific characteristics of immune responses.
Issa F
Transpl Int; 2016 Jun; 29(6):672-81. PubMed ID: 26927941
[TBL] [Abstract][Full Text] [Related]
17. Mixed allogeneic chimerism and tolerance to composite tissue allografts.
Prabhune KA; Gorantla VS; Maldonado C; Perez-Abadia G; Barker JH; Ildstad ST
Microsurgery; 2000; 20(8):441-7. PubMed ID: 11150997
[TBL] [Abstract][Full Text] [Related]
18. Advances in the development of experimental composite tissue transplantation models.
Siemionow M; Klimczak A
Transpl Int; 2010 Jan; 23(1):2-13. PubMed ID: 19719468
[TBL] [Abstract][Full Text] [Related]
19. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.
Foster RD; Ascher NL; McCalmont TH; Neipp M; Anthony JP; Mathes SJ
Transplantation; 2001 Sep; 72(5):791-7. PubMed ID: 11571439
[TBL] [Abstract][Full Text] [Related]
20. Fifteen years later: main lessons from composite tissue allografts.
Dubernard JM; Sirigu A; Seulin C; Morelon E; Petruzzo P
Clin Transpl; 2013; ():113-9. PubMed ID: 25095499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
